Company / Free Cash Flow per Share
Cullinan Therapeutics, Inc. Free Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.48
FY2024
5-year range
-$3.24 / -$1.00
FY2020-FY2024
Trend
+23.3%
vs FY2023
Sector context
#141 of 192
Health Care
What the data says
At $-2.48, Cullinan Therapeutics, Inc.'s free cash flow per share ranks #141 of 192 in the Health Care sector. Free Cash Flow per Share returned to growth in FY2024 after 2 years of decline, reaching $-2.48.
Based on SEC 10-K filings.
-2.48 in FY2024.
Improved from $-2.79 to $-2.48 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#141 of 192 in Health CareTop 73% of 192This company -$2.48 Sector average -$19.85
▼
+87.5% above sector average
Key checks
Key Insights
- In FY2024, free cash flow per share increased 23.3% year-over-year.
- Ranks #141 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$2.48 | +23.3% |
| FY2023 | -$3.24 | -16.0% |
| FY2022 | -$2.79 | -179.5% |
| FY2021 | -$1.00 | +33.3% |
| FY2020 | -$1.50 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026